[H22-02] Implantation via injection under endoscopic ultrasound guidance of 32P-labeled microparticles for unresectable, locally advanced pancreatic tumours - Addendum to commission H21-13
Last updated 15.06.2022
Project no.:
H22-02
Commission:
Commission awarded on 24.03.2022 by the Federal Joint Committee (G-BA).
Report type:
Assessment according to §137h SGB V
Status:
Commission completed
Department/Division:
Non-Drug Interventions
Topic:
Cancer
Note:
Within the framework of procedures according to §137h SGB V, the G-BA can commission IQWiG with the systematic examination of an assessment result (addendum) according to 137h SGB V. The assessment is usually published 2 weeks after it was sent to the G-BA.
| Project no. | Title | Status |
|---|---|---|
| H21-13 | Implantation via injection under endoscopic ultrasound guidance of 32P-labeled microparticles for unresectable, locally advanced pancreatic tumours | Commission completed |